Graves’ disease with spontaneous resolution following ocrelizumab in primary progressive multiple sclerosis
Authors
Diana Borges Duarte
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar e Universitario do Porto, Oporto, Portugal
Ana Martins da Silva
Department of Neurology, Centro Hospitalar e Universitario do Porto, Oporto, Portugal
Claudia Freitas
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar e Universitario do Porto, Oporto, Portugal
Helena Cardoso
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar e Universitario do Porto, Oporto, Portugal
Language: English
Page range: 169 - 173
Published on: Sep 13, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Related subjects:
© 2021 Diana Borges Duarte, Ana Martins da Silva, Claudia Freitas, Helena Cardoso, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.